Literature DB >> 28874432

Stopping anticoagulation in a woman with unprovoked venous thromboembolism.

Faizan Khan1, Grégoire Le Gal1, Marc A Rodger2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28874432      PMCID: PMC5589452          DOI: 10.1503/cmaj.170327

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.

Authors:  John Simes; Cecilia Becattini; Giancarlo Agnelli; John W Eikelboom; Adrienne C Kirby; Rebecca Mister; Paolo Prandoni; Timothy A Brighton
Journal:  Circulation       Date:  2014-08-25       Impact factor: 29.690

2.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  Travel and venous thrombosis: a systematic review.

Authors:  S Kuipers; A J M Schreijer; S C Cannegieter; H R Büller; F R Rosendaal; S Middeldorp
Journal:  J Intern Med       Date:  2007-12       Impact factor: 8.989

4.  Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.

Authors:  Jeffrey I Weitz; Anthonie W A Lensing; Martin H Prins; Rupert Bauersachs; Jan Beyer-Westendorf; Henri Bounameaux; Timothy A Brighton; Alexander T Cohen; Bruce L Davidson; Hervé Decousus; Maria C S Freitas; Gerlind Holberg; Ajay K Kakkar; Lloyd Haskell; Bonno van Bellen; Akos F Pap; Scott D Berkowitz; Peter Verhamme; Philip S Wells; Paolo Prandoni
Journal:  N Engl J Med       Date:  2017-03-18       Impact factor: 91.245

5.  Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence.

Authors:  A Hamadah; T Alwasaidi; G LE Gal; M Carrier; P S Wells; D Scarvelis; C Gonsalves; M Forgie; M J Kovacs; M A Rodger
Journal:  J Thromb Haemost       Date:  2011-12       Impact factor: 5.824

6.  Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH.

Authors:  C Kearon; W Ageno; S C Cannegieter; B Cosmi; G-J Geersing; P A Kyrle
Journal:  J Thromb Haemost       Date:  2016-06-07       Impact factor: 5.824

7.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors:  Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal:  Chest       Date:  2016-01-07       Impact factor: 9.410

Review 8.  Unprovoked venous thromboembolism: Short term or indefinite anticoagulation? Balancing long-term risk and benefit.

Authors:  M Rodger; M Carrier; E Gandara; G Le Gal
Journal:  Blood Rev       Date:  2010-07-14       Impact factor: 8.250

9.  Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy.

Authors:  Marc A Rodger; Susan R Kahn; Philip S Wells; David A Anderson; Isabelle Chagnon; Grégoire Le Gal; Susan Solymoss; Mark Crowther; Arnaud Perrier; Richard White; Linda Vickars; Tim Ramsay; Marisol T Betancourt; Michael J Kovacs
Journal:  CMAJ       Date:  2008-08-26       Impact factor: 8.262

10.  Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.

Authors:  Marc A Rodger; Gregoire Le Gal; David R Anderson; Jeannot Schmidt; Gilles Pernod; Susan R Kahn; Marc Righini; Patrick Mismetti; Clive Kearon; Guy Meyer; Antoine Elias; Tim Ramsay; Thomas L Ortel; Menno V Huisman; Michael J Kovacs
Journal:  BMJ       Date:  2017-03-17
View more
  2 in total

1.  Thrombophilia testing in venous thromboembolism.

Authors:  Habib U Rehman
Journal:  CMAJ       Date:  2018-02-12       Impact factor: 8.262

2.  The authors respond to "Thrombophilia testing in venous thromboembolism".

Authors:  Faizan Khan; Grégoire Le Gal; Marc A Rodger
Journal:  CMAJ       Date:  2018-02-12       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.